What is NDC 51662-1459?

51662-1459 is the product NDC for Amidate(Tm) Etomidate, Etomidate 2 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Amidate(Tm) Etomidate?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Amidate(Tm) Etomidate NDC 51662-1459 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1459Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1459Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1459-1	51662145901	10 mL in 1 VIAL, SINGLE-USE (51662-1459-1)Marketed from Mar 31, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amidate(Tm) Etomidate
Generic name (nonproprietary): amidate(tm) etomidate
Active ingredients: Etomidate — 2 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018227
Marketing start: Mar 31, 2020
Listing expires: Dec 31, 2026
Other FDA classes: General Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1459_0762982e-561c-4595-e063-6394a90a58b3SPL ID 0762982e-561c-4595-e063-6394a90a58b3SPL set ID a227d2f1-3eef-4ac6-e053-2995a90a5340RxCUI 1654006UNII Z22628B598
Pharmacologic class: General Anesthetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662145901 followed by a unit qualifier and the quantity

Package 51662-1459-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 10, 2023.

Indications (excerpt from the label)

INDICATIONS & USAGE AMIDATE is indicated by intravenous injection for the induction of general anesthesia. When considering use of AMIDATE, the usefulness of its hemodynamic properties (see CLINICAL PHARMACOLOGY ) should be weighed against the high frequency of transient skeletal muscle movements (see ADVERSE REACTIONS ). Intravenous AMIDATE is also indicated for the supplementation of subpotent anesthetic agents, such as nitrous oxide in oxygen, during maintenance of anesthesia for short operative procedures such as dilation and curettage or cervical conization.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1459

What is NDC 51662-1459?: 51662-1459 is the product NDC for Amidate(Tm) Etomidate, Etomidate 2 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Amidate(Tm) Etomidate.
What is the active ingredient?: Etomidate.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Amidate(Tm) Etomidate?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 018227

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018227
Product	Strength	Form · route	Labeler	Product NDC
Amidateetomidate	Etomidate 2 mg/mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-6695
Amidateetomidate	Etomidate 2 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9811